| Application number | Title of the application | Filing Date | Status |
|---|
| 09/553927 | Methods for identifying compounds useful for preventing acute clinical vascular events in a subject | Apr 20, 2000 | Abandoned |
Array
(
[id] => 1364751
[patent_doc_number] => 06566047
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-20
[patent_title] => 'Method for identifying neurite-growth promoting agents'
[patent_app_type] => B1
[patent_app_number] => 09/463259
[patent_app_country] => US
[patent_app_date] => 2000-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 23107
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/566/06566047.pdf
[firstpage_image] =>[orig_patent_app_number] => 09463259
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/463259 | Method for identifying neurite-growth promoting agents | Apr 17, 2000 | Issued |
| 09/547580 | Method of diagnosing transmissible spongiform encephalopathies | Apr 11, 2000 | Abandoned |
| 09/547276 | Clasp-2 transmembrane proteins | Apr 10, 2000 | Abandoned |
Array
(
[id] => 1528711
[patent_doc_number] => 06479638
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-12
[patent_title] => 'Antibodies that specifically bind DNAX leukocyte associated immunoglobulin-like receptor'
[patent_app_type] => B1
[patent_app_number] => 09/546049
[patent_app_country] => US
[patent_app_date] => 2000-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46287
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/479/06479638.pdf
[firstpage_image] =>[orig_patent_app_number] => 09546049
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/546049 | Antibodies that specifically bind DNAX leukocyte associated immunoglobulin-like receptor | Apr 9, 2000 | Issued |
Array
(
[id] => 736751
[patent_doc_number] => 07033784
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-04-25
[patent_title] => 'Method of producing an erythroid cell which is undifferentiated yet capable of expressing a heterologous protein'
[patent_app_type] => utility
[patent_app_number] => 10/009231
[patent_app_country] => US
[patent_app_date] => 2000-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9825
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/033/07033784.pdf
[firstpage_image] =>[orig_patent_app_number] => 10009231
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/009231 | Method of producing an erythroid cell which is undifferentiated yet capable of expressing a heterologous protein | Apr 4, 2000 | Issued |
| 09/542415 | Mouse edg5 gene | Apr 3, 2000 | Abandoned |
| 09/541919 | Testis specific protein | Apr 2, 2000 | Abandoned |
| 09/541226 | Promoting cell growth by inhibiting enabled proteins or their ligands | Apr 2, 2000 | Abandoned |
Array
(
[id] => 7634711
[patent_doc_number] => 06656907
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-02
[patent_title] => 'Method of treating gastric ulcer by administration of epidermal growth factor'
[patent_app_type] => B1
[patent_app_number] => 09/518135
[patent_app_country] => US
[patent_app_date] => 2000-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4176
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/656/06656907.pdf
[firstpage_image] =>[orig_patent_app_number] => 09518135
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/518135 | Method of treating gastric ulcer by administration of epidermal growth factor | Mar 2, 2000 | Issued |
Array
(
[id] => 1182022
[patent_doc_number] => 06737509
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-05-18
[patent_title] => 'Zinsi polypeptide composition stimulating pancreatic islet growth'
[patent_app_type] => B1
[patent_app_number] => 09/518842
[patent_app_country] => US
[patent_app_date] => 2000-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 18057
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/737/06737509.pdf
[firstpage_image] =>[orig_patent_app_number] => 09518842
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/518842 | Zinsi polypeptide composition stimulating pancreatic islet growth | Mar 2, 2000 | Issued |
| 09/518866 | NUCLEIC ACID MOLECULES ENCODING TWIK-6 A NOVEL POTASSIUM CHANNEL PROTEIN | Mar 2, 2000 | Abandoned |
| 09/515520 | NUCLEIC ACIDS ENCODING TWIK-7, A NOVEL POTASSIUM CHANNEL PROTEIN | Feb 28, 2000 | Abandoned |
Array
(
[id] => 793315
[patent_doc_number] => 06982361
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-01-03
[patent_title] => 'Method of screening a compound for anxiolytic activity in an Apolipoprotein e knockout animal'
[patent_app_type] => utility
[patent_app_number] => 09/512840
[patent_app_country] => US
[patent_app_date] => 2000-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 20
[patent_no_of_words] => 9298
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/982/06982361.pdf
[firstpage_image] =>[orig_patent_app_number] => 09512840
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/512840 | Method of screening a compound for anxiolytic activity in an Apolipoprotein e knockout animal | Feb 24, 2000 | Issued |
Array
(
[id] => 1474091
[patent_doc_number] => 06387664
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-14
[patent_title] => 'Sparc fusion protein and method for producing the same'
[patent_app_type] => B1
[patent_app_number] => 09/513442
[patent_app_country] => US
[patent_app_date] => 2000-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10272
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/387/06387664.pdf
[firstpage_image] =>[orig_patent_app_number] => 09513442
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/513442 | Sparc fusion protein and method for producing the same | Feb 24, 2000 | Issued |
Array
(
[id] => 1558443
[patent_doc_number] => 06436388
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-08-20
[patent_title] => 'Method of treating rhabdomyolysis by administering hepatocyte growth factor'
[patent_app_type] => B2
[patent_app_number] => 09/381031
[patent_app_country] => US
[patent_app_date] => 2000-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3872
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/436/06436388.pdf
[firstpage_image] =>[orig_patent_app_number] => 09381031
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/381031 | Method of treating rhabdomyolysis by administering hepatocyte growth factor | Feb 23, 2000 | Issued |
Array
(
[id] => 1105618
[patent_doc_number] => 06812327
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-11-02
[patent_title] => 'Neutrokine-alpha polypeptides'
[patent_app_type] => B1
[patent_app_number] => 09/507968
[patent_app_country] => US
[patent_app_date] => 2000-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 34
[patent_no_of_words] => 168194
[patent_no_of_claims] => 223
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/812/06812327.pdf
[firstpage_image] =>[orig_patent_app_number] => 09507968
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/507968 | Neutrokine-alpha polypeptides | Feb 21, 2000 | Issued |
Array
(
[id] => 5922912
[patent_doc_number] => 20020115598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-22
[patent_title] => 'METHOD FOR THE IMPROVEMENT OF NEURONAL REGENERATION'
[patent_app_type] => new
[patent_app_number] => 09/423622
[patent_app_country] => US
[patent_app_date] => 2000-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4066
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20020115598.pdf
[firstpage_image] =>[orig_patent_app_number] => 09423622
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/423622 | METHOD FOR THE IMPROVEMENT OF NEURONAL REGENERATION | Feb 7, 2000 | Abandoned |
Array
(
[id] => 1034365
[patent_doc_number] => 06875574
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-04-05
[patent_title] => 'Assays for sensory modulators using a sensory cell specific G-protein alpha subunit'
[patent_app_type] => utility
[patent_app_number] => 09/492028
[patent_app_country] => US
[patent_app_date] => 2000-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23822
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/875/06875574.pdf
[firstpage_image] =>[orig_patent_app_number] => 09492028
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/492028 | Assays for sensory modulators using a sensory cell specific G-protein alpha subunit | Jan 25, 2000 | Issued |
| 09/491896 | Method for modifying target receptor function associated with neurological disorders | Jan 23, 2000 | Abandoned |